Swedencare AB (publ) Stock Nasdaq Stockholm
Stocks
SE0008294078
Pharmaceuticals
OTC Markets Traded| Market Cap | 3.52B 367M 315M 297M 271M 505M 34.78B 508M 1.36B 17.78B 1.38B 1.35B 56.58B | P/E 2026 * |
23.4x | P/E 2027 * | 15.1x |
|---|---|---|---|---|---|
| Enterprise Value | 5.01B 522M 449M 423M 386M 720M 49.53B 723M 1.94B 25.32B 1.96B 1.92B 80.57B | EV / Sales 2026 * |
1.75x | EV / Sales 2027 * | 1.56x |
| Free-Float |
32.62% | Yield 2026 * |
2.02% | Yield 2027 * | 3.17% |
Last Transcript : Swedencare AB (publ)
| 1 day | -4.16% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 01/01/2014 | |
Jenny Graflind
CEO | Chief Executive Officer | 50 | 01/11/2019 |
Annie Bengtsson
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 59 | 01/01/2026 | |
| Director/Board Member | 63 | 01/01/2019 | |
Johan Bergdahl
BRD | Director/Board Member | 56 | 01/01/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.16% | -5.47% | - | - | 367M | |
| -2.31% | -3.92% | -51.09% | -60.05% | 31.33B | |
| -1.96% | +0.69% | +26.38% | +107.72% | 12.24B | |
| +2.32% | +2.08% | -9.82% | +7.56% | 3.96B | |
| +0.64% | -2.02% | -2.77% | +19.02% | 3.06B | |
| +0.98% | -1.58% | +52.02% | +34.71% | 2B | |
| -0.44% | -3.00% | +9.66% | +17.47% | 1.88B | |
| -1.62% | -1.88% | -4.51% | +199.52% | 1.55B | |
| -0.33% | +4.74% | -16.23% | +0.22% | 1.23B | |
| +2.27% | +5.42% | -3.23% | -37.34% | 1.07B | |
| Average | -0.42% | +1.15% | +0.05% | +32.09% | 6.48B | |
| Weighted average by Cap. | -1.44% | -0.35% | -21.15% | -1.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.85B 298M 256M 241M 220M 410M 28.23B 412M 1.1B 14.43B 1.12B 1.09B 45.92B | 3.12B 326M 280M 264M 241M 449M 30.91B 451M 1.21B 15.8B 1.22B 1.2B 50.27B |
| Net income | 131M 13.69M 11.77M 11.07M 10.1M 18.85M 1.3B 18.95M 50.75M 663M 51.39M 50.27M 2.11B | 216M 22.55M 19.39M 18.24M 16.65M 31.07M 2.14B 31.23M 83.63M 1.09B 84.69M 82.84M 3.48B |
| Net Debt | 1.49B 156M 134M 126M 115M 214M 14.75B 215M 577M 7.54B 584M 571M 23.99B | 1.37B 142M 122M 115M 105M 196M 13.51B 197M 528M 6.9B 535M 523M 21.97B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
